Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Tran, Pierre V.
Tollefson, Gary D.
Sanger, Todd M.
Lu, Yili
Berg, Paul H.
and
Beasley, Charles M.
1999.
Olanzapine versus haloperidol in the treatment of schizoaffective disorder.
British Journal of Psychiatry,
Vol. 174,
Issue. 1,
p.
15.
Massie, Jennifer
and
Lewis, Shôn
1999.
Duration of treatment in schizophrenia.
The Journal of Forensic Psychiatry,
Vol. 10,
Issue. 3,
p.
491.
Fleischhacker, W. Wolfgang
1999.
Invited comment.
Acta Psychiatrica Scandinavica,
Vol. 100,
Issue. 4,
p.
314.
Kane, John
1999.
Olanzapine in the long-term treatment of schizophrenia.
British Journal of Psychiatry,
Vol. 174,
Issue. S37,
p.
26.
Green, Ben
1999.
Focus on Olanzapine.
Current Medical Research and Opinion,
Vol. 15,
Issue. 2,
p.
79.
Stephenson, C. M. E.
and
Pilowsky, L. S.
1999.
Psychopharmacology of olanzapine.
British Journal of Psychiatry,
Vol. 174,
Issue. S38,
p.
52.
Fleischhacker, W. Wolfgang
1999.
The psychopharmacology of schizophrenia.
Current Opinion in Psychiatry,
Vol. 12,
Issue. 1,
p.
53.
Sacristán, José A.
Gómez, Juan-Carlos
Montejo, Angel-Luis
Vieta, Eduardo
and
Gregor, Karl J.
2000.
Doses of olanzapine, risperidone, and haloperidol used in clinical practice: Results of a prospective pharmacoepidemiologic study.
Clinical Therapeutics,
Vol. 22,
Issue. 5,
p.
583.
Lund, Brian C
and
Perry, Paul J
2000.
Olanzapine: an atypical antipsychotic for schizophrenia.
Expert Opinion on Pharmacotherapy,
Vol. 1,
Issue. 2,
p.
305.
Revicki, Dennis A
2000.
The new atypical antipsychotics: a review of pharmacoeconomic studies.
Expert Opinion on Pharmacotherapy,
Vol. 1,
Issue. 2,
p.
249.
Duggan, L
Fenton, M
Dardennes, RM
El-Dosoky, A
and
Indran, S
2000.
Cochrane Database of Systematic Reviews.
Fleischhacker, W. W.
2000.
Psychiatrie der Gegenwart 5.
p.
209.
Tollefson, Gary D.
and
Taylor, Cindy C.
2000.
Olanzapine: Preclinical and Clinical Profiles of a Novel Antipsychotic Agent.
CNS Drug Reviews,
Vol. 6,
Issue. 4,
p.
303.
Marder, Stephen R.
2000.
Newer antipsychotics.
Current Opinion in Psychiatry,
Vol. 13,
Issue. 1,
p.
11.
Möller, Hans-Jürgen
2000.
Definition, Psychopharmacological Basis and Clinical Evaluation of Novel/Atypical Neuroleptics: Methodological Issues and Clinical Consequences.
The World Journal of Biological Psychiatry,
Vol. 1,
Issue. 2,
p.
75.
Dose, M.
2000.
Langzeittherapie der Schizophrenie.
p.
37.
Meltzer, Herbert Y.
2000.
Atypical Antipsychotics.
p.
191.
Kasper, S.
Jones, M.
and
Duchesne, I.
2001.
Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): health economic results of an international naturalistic study.
International Clinical Psychopharmacology,
Vol. 16,
Issue. 4,
p.
189.
Edell, William S.
and
Tunis, Sandra L.
2001.
Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia in Geropsychiatric Inpatients.
The American Journal of Geriatric Psychiatry,
Vol. 9,
Issue. 3,
p.
289.
Bosveld‐van Haandel, L. J. M.
Slooff, C. J.
and
Van Den Bosch, R. J.
2001.
Reasoning about the optimal duration of prophylactic antipsychotic medication in schizophrenia: evidence and arguments.
Acta Psychiatrica Scandinavica,
Vol. 103,
Issue. 5,
p.
335.
eLetters
No eLetters have been published for this article.